Accuray Inc revenue by segment ARAY

Annual Quarterly

Accuray Inc splits its revenue into 2 lines in its filings. The largest line in Q4 of fiscal 2026, the quarter ended Jun 30, 2026 was Services at $60.1 million, 60% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	Q4 FY2026 Jun 30, 2026	Q3 FY2026 Mar 31, 2026	Q2 FY2026 Dec 31, 2025	Q1 FY2026 Sep 30, 2025	Q4 FY2025 Jun 30, 2025	Q3 FY2025 Mar 31, 2025	Q2 FY2025 Dec 31, 2024	Q1 FY2024 Sep 30, 2024
Revenue	101	105	102	94	128	113	116	102
Services	60 +5.7% share 59.5%	55 -1.4% share 52.6%	57 +4.1% share 56.0%	57 share 60.4%	57 share 44.6%	56 share 49.4%	55 share 47.3%	53 share 52.4%
Product	41 -42.2% share 40.5%	50 -13.3% share 47.4%	45 -26.4% share 44.0%	37 share 39.6%	71 share 55.4%	57 share 50.6%	61 share 52.7%	48 share 47.6%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: ARAY (Nasdaq)
Fiscal year ends: June 30
Incorporated in: DE
Headquarters: Madison, WI
SEC filer status: Accelerated filer, Smaller reporting company
SEC CIK: 1138723

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.